Showing results (251-260 of 320) with videos related to

Sort By:
Pageof 32
Journal of Affective Disorders|October 7, 2022
Sex-dependent differences in the stress mitigating and antidepressant effects of selective aryl hydrocarbon receptor modulatorsCaitlin A Madison, Roanna A Debler, Nathan I Vardeleon, et al.
Molecular Cancer Therapeutics|March 18, 2004
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanesChunhua Qin, Derek Morrow, Jessica Stewart, et al.
Molecular Cancer Therapeutics|December 17, 2008
ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cellsSeong-Ho Lee, Jae Hoon Bahn, Chang Kyoung Choi, et al.
Molecular Cancer Therapeutics|October 29, 2011
Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cellsShu Zhang, KyoungHyun Kim, Un Ho Jin, et al.
Molecular Pharmacology|March 1, 2025
Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST1Srijana Upadhyay, Miok Lee, Lei Zhang, et al.
Neurotoxicology|June 5, 2024
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) induces depression-like phenotypeRoanna A Debler, Paula L Gallegos, Alexandra C Ojeda, et al.
Diabetes|June 21, 2023
Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy ExpenditureQuan Pan, Weiqi Ai, Yunmei Chen, et al.
Molecular Cancer Therapeutics|May 3, 2014
MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expressionZichao Zhang, KyoungHyun Kim, Xiao Li, et al.
Molecular Pharmacology|April 11, 2015
The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κBBriana R De Miranda, Katriana A Popichak, Sean L Hammond, et al.
The Biochemical Journal|September 9, 2020
Dopamine is an aryl hydrocarbon receptor agonistHyejin Park, Un-Ho Jin, Keshav Karki, et al.
Pageof 32